ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2447

The Role of TET3-Mediated DNA Demethylation By Pro-Inflammatory Cytokines in Rheumatoid Arthritis

Kazuhisa Nakano1, Kunihiro Yamaoka1, Akira Kurozumi2, Akio Kawabe2, Kaoru Yamagata2 and Yoshiya Tanaka3, 1The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 2The first department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 3University of Occupational and Environmental Health, Japan, Kitakyushu, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: DNA Methylation, Epigenetics, pathogenesis, rheumatoid arthritis, synovial cells, synovial fluid and tumor necrosis factor (TNF)

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Session Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose

In the pathogenesis of Rheumatoid arthritis (RA) RA fibroblast-like synoviocytes (RA FLS) exhibit a unique aggressive phenotype that contributes to the cytokine milieu and joint destruction. We previously revealed that persistent exposure of pro-inflammatory cytokines contribute to passive DNA demethylation through decreased expression of DNMT in FLS. We here assessed the involvement of a novel active DNA demethylation enzyme, Ten-eleven-translocation (TET), in cytokine-mediated activation of RA-FLS. 

Methods

FLS were obtained from patients with RA and osteoarthritis (OA) synovium at total joint replacement and studied in the 4th through 6th passage. The study was approved by the ethical committee of the university and informed consents were obtained by each patient. cDNA, Nuclear extracts and genomic DNA were purified from control or stimulated FLS. Gene expression was determined by qPCR and protein expression by Western blot and immunostaining. 5-hmC was determined by dot blot. Secretion of cytokines and MMPs was measured by Cytometric Bead Array and latex agglutination method. Cell migration was assessed using a wound healing scratch assay.

Results

TET3 and its product, 5-hydroxymethylcytosine (5-hmC), are detected in the intimal lining layer of synovium in patients with active RA, while TET1 and TET2 were observed marginally there. TET3 was characteristically expressed in both cytoplasm and nuclear of FLS, whereas TET1 and TET2 were not detected in nucleus. Although unstimulated RA and OA FLS expressed similar amounts of TET3 mRNA (n=6 each; n.s.), stimulation with TNFα (10 ng/ml) and IL-1β (1 ng/ml) for 2 hrs significantly increased TET3 mRNA expression in FLS (>3-fold and >4-fold respectively). Western blot analysis showed expression levels of TET3 protein in nucleus in RA FLS were significantly increased by stimulation with TNFα within 48 hrs and were maintained for 96 hrs. Dot blot analysis showed that 5-hmC was also increased by TNFα when FLS were cultured continuously for 96 hrs with TNFα. TET3-knockdown of FLS with siRNA not only inhibited TNF-induced expression of key migratory genes, including CCL2 and ICAM-1, but also reduced TNF-induced FLS-migration completely.

Conclusion

We initially report that a novel DNA methylation enzyme TET3 is characteristically induced in RA FLS through TNF/IL-1 stimulation. Taken together with our previous report, persistent exposure to pro-inflammatory cytokines in the synovium not only decreases DNMT expression but also increases TET3 expression, resulting in promotion of DNA demethylation. In addition to demonstrating a critical role for TET3 in FLS in cytokine milieu, our study suggests that targeting the TET3-5-hmC pathway may be a therapeutic strategy for preventing FLS from TNF-mediated imprinting in RA.


Disclosure:

K. Nakano,
None;

K. Yamaoka,
None;

A. Kurozumi,
None;

A. Kawabe,
None;

K. Yamagata,
None;

Y. Tanaka,
None.

  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-tet3-mediated-dna-demethylation-by-pro-inflammatory-cytokines-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.